关注
Maxim Poustovoitov
Maxim Poustovoitov
Senior Research Scientist, ISCO
在 intlstemcell.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA
R Zhang, MV Poustovoitov, X Ye, HA Santos, W Chen, SM Daganzo, ...
Developmental cell 8 (1), 19-30, 2005
8132005
Structure of a human ASF1a–HIRA complex and insights into specificity of histone chaperone complex assembly
Y Tang, MV Poustovoitov, K Zhao, M Garfinkel, A Canutescu, R Dunbrack, ...
Nature structural & molecular biology 13 (10), 921-929, 2006
2202006
Neural stem cells derived from human parthenogenetic stem cells engraft and promote recovery in a nonhuman primate model of Parkinson's disease
R Gonzalez, I Garitaonandia, M Poustovoitov, T Abramihina, C McEntire, ...
Cell transplantation 25 (11), 1945-1966, 2016
802016
Neural stem cell tumorigenicity and biodistribution assessment for phase I clinical trial in Parkinson’s disease
I Garitaonandia, R Gonzalez, T Christiansen-Weber, T Abramihina, ...
Scientific Reports 6 (1), 34478, 2016
742016
Proof of concept studies exploring the safety and functional activity of human parthenogenetic-derived neural stem cells for the treatment of Parkinson's disease
R Gonzalez, I Garitaonandia, A Crain, M Poustovoitov, T Abramihina, ...
Cell transplantation 24 (4), 681-690, 2015
642015
Varicella-zoster virus immediate-early 63 protein interacts with human antisilencing function 1 protein and alters its ability to bind histones h3. 1 and h3. 3
AP Ambagala, T Bosma, MA Ali, M Poustovoitov, JJ Chen, MD Gershon, ...
Journal of virology 83 (1), 200-209, 2009
492009
A two-step two-hybrid system to identify functionally significant protein–protein interactions
M Poustovoitov, I Serebriiskii, PD Adams
Methods 32 (4), 371-380, 2004
52004
Small molecules that promote skin regeneration
R Gonzalez, M Poustovoitov, R Semechkin
US Patent 9,375,439, 2016
12016
Transplantation of neural stem cells into patients with Parkinson’s Disease (P3. 360)
R Semechkin, I Garitaonandia, R Gonzalez, M Poustovoitov, ...
Neurology 86 (16_supplement), P3. 360, 2016
12016
Formation of macroH2A-containing senescence associated heterochromatin foci (SAHF) and senescence driven by ASF1A and HIRA
R Zhang, RG Zhang, MV Poustovoitov, XF Ye, HA Santos, W Chen, ...
Gerontologist 45, 46-46, 2005
12005
Biochemical Analysis of the Cell Cycle and Cell Cycle Checkpoints in Transiently Transfected Cells After Collection With Magnetic Beads
X Ye, M Poustovoitov, H Santos, DM Nelson, PD Adams
Checkpoint Controls and Cancer: Volume 2: Activation and Regulation …, 2004
12004
Small molecules that promote skin regeneration
R Gonzalez, M Poustovoitov, RA Kern
US Patent 10,335,422, 2019
2019
CT-1518 Provisionally Accepted 05/18/2016 for publication in “Cell Transplantation” Neural Stem Cells Derived from Human Parthenogenetic Stem Cells Engraft and Promote Recovery …
R Gonzalez, I Garitaonandia, M Poustovoitov, T Abramihina, C McEntire, ...
2016
A Neural Stem Cell-Based Therapy for Parkinson's Disease
R Gonzalez, I Garitaonandia, M Poustovoitov, T Abramihina, CR McEntire, ...
CELL TRANSPLANTATION 25 (4), 758-759, 2016
2016
Human parthenogenetic derived neural stem cells for the treatment of parkinson’s disease
R Semechkin, R Gonzalez, I Garitaonandia, M Poustovoitov, ...
Cytotherapy 17 (6), S16, 2015
2015
Neural Stem Cell Based Therapy For Parkinson’s Disease (S48. 007)
R Semechkin, R Gonzalez, I Garitaonandia, T Abramihina, ...
Neurology 84 (14_supplement), S48. 007, 2015
2015
Human Parthenogenetic Stem Cell-Derived Neural Stem Cells Are Safe and Well Tolerated by a Nonhuman Primate Model of Parkinson's Disease
R Gonzalez, I Garitaonandia, M Poustovoitov, A Crain, T Abramihina, ...
CELL TRANSPLANTATION 24 (4), 759-760, 2015
2015
715. KEL-Null Red Blood Cells Derived From In Vitro Differentiation of Zinc-Finger Nuclease-Edited HSCs
R Semechkin, R Gonzalez, I Garitaonandia, A Ostrowska, T Abramihina, ...
Molecular Therapy 22, 1, 2014
2014
Safety and efficacy of human neural stem cells in a large-scale non-human primate study
RA Semechkin, R Gonzalez, A Crain, A Ostrowska, T Abramihina, ...
MOVEMENT DISORDERS 29, S43-S43, 2014
2014
Large-Scale Efficacy, Pharmacology and Toxicology Study of Human Parthenogenetic Stem Cell Derived Neural Stem Cells in Non-Human Primate Model of Parkinson's Disease
R Semechkin, R Gonzalez, I Garitaonandia, A Ostrowska, T Abramihina, ...
MOLECULAR THERAPY 22, S276-S276, 2014
2014
系统目前无法执行此操作,请稍后再试。
文章 1–20